Retrospective analysis on the effects of house dust mite specific immunotherapy for more than 3 years in atopic dermatitis

Yonsei Medical Journal

Volumn 57, Issue 2, 2016, Pages 393-398

  Lee, Jungsoo ^a   Lee, Hemin ^a   Noh, Seongmin ^a   Bae, Byung Gi ^a   Shin, Jung U ^a   Park, Chang Ook ^a   Lee, Kwang Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Allergen specific immunotherapy; Atopic dermatitis; House dust mites

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ATOPIC DERMATITIS; DERMATOPHAGOIDES; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRICK TEST; PRURITUS; RASH; REMISSION; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SKIN SENSITIZATION; SLEEP DISORDER; TREATMENT RESPONSE; URTICARIA; VISUAL ANALOG SCALE; ADOLESCENT; ANIMAL; CHILD; DERMATITIS, ATOPIC; DESENSITIZATION; DOSE RESPONSE; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; PYROGLYPHIDAE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; CHILD; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PYROGLYPHIDAE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84956933253     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2016.57.2.393     Document Type: Article

References (27)

1. Lee J, Park CO, Lee KH. Specific immunotherapy in atopic dermatitis. Allergy Asthma Immunol Res 2015;7:221-9.
2. Silverberg JI. Atopic dermatitis: an evidence-based treatment update. Am J Clin Dermatol 2014;15:149-64.
3. Bussmann C, Bockenhoff A, Henke H, Werfel T, Novak N. Does allergen- specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006;118: 1292-8.
4. Hur GY, Kim TB, Han MY, Nahm DH, Park JW; Allergen and Immunotherapy Work Group of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI). A survey of the prescription patterns of allergen immunotherapy in Korea. Allergy Asthma Immunol Res 2013;5:277-82.
5. Creticos PS, Adkinson NF Jr, Kagey-Sobotka A, Proud D, Meier HL, Naclerio RM, et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 1985;76: 2247-53.
6. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102(4 Pt 1):558-62.
7. Nahm DH, Cho SM, Kim ME, Kim YJ, Jeon SY. Autologous immunoglobulin therapy in patients with severe recalcitrant atopic dermatitis: a preliminary report. Allergy Asthma Immunol Res 2014; 6:89-94.
8. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978;2:912-5.
9. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992;22:440-6.
10. Leroy BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993;28(2 Pt 1):232-9.
11. Darsow U, Forer I, Ring J. Allergen-specific immunotherapy in atopic eczema. Curr Allergy Asthma Rep 2011;11:277-83.
12. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111:1255-61.
13. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
14. James LK, Durham SR. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy 2008;38:1074-88.
15. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen- IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003;112:915-22.
16. van Neerven RJ, Arvidsson M, Ipsen H, Sparholt SH, Rak S, Wurtzen PA. A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 2004;34:420-8.
17. Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergenspecific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013;132:110-7.
18. Wuthrich B. [Atopic neurodermatitis]. Wien Med Wochenschr 1989; 139:156-65.
19. Garmhausen D, Hagemann T, Bieber T, Dimitriou I, Fimmers R, Diepgen T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 2013;68:498-506.
20. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
21. Weidinger S, Rodriguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007;127:724-6.
22. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011;365:1315-27.
23. Kezic S, O'Regan GM, Yau N, Sandilands A, Chen H, Campbell LE, et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 2011; 66:934-40.
24. Thyssen JP, Linneberg A, Johansen JD, Carlsen BC, Zachariae C, Meldgaard M, et al. Atopic diseases by filaggrin mutations and birth year. Allergy 2012;67:705-8.
25. Novak N, Bieber T, Hoffmann M, Folster-Holst R, Homey B, Werfel T, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol 2012;130:925-31.e4.
26. Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010;11:351-61.
27. Ferreira F, Wolf M, Wallner M. Molecular approach to allergy diagnosis and therapy. Yonsei Med J 2014;55:839-52.